1. Morton
H, Cavanagh AC, Athanasas-Platsis S, et al.: Early pregnancy factor has
immunosuppressive and growth factor properties. Reprod Fertil Dev 4:411-22,
1992.
2. Morton H, Rolfe BE, Cavanagh AC:
Pregnancy proteins: basic concepts and clinical applications. Semin Reprod
Endocrinol 10:72, 1992.
3. Cavanagh AC, Morton H, Rolfe BE, et
al.: Ovum factor: a first signal of pregnancy? Am J Reprod Immunol 2:97-101,
1982.
4. Morton H, Rolfe BE, Cavanagh AC: Ovum
factor and early pregnancy factor. Curr Top Dev Biol 23:73-92, 1987.
5. Croxatto HB, Ortiz ME, Diaz S, et al.:
Studies on the duration of egg transport by the human oviduct. II. Ovum
location at various intervals following luteinizing hormone peak. Am J Obstet
Gynecol 132:629-34, 1978.
6. Buster JE, Bustillo M, Rodi IA, et al.:
Biologic and morphologic development of donated human ova recovered by
nonsurgical uterine lavage. Am J Obstet Gynecol 153:211-7, 1985.
7. The morphological and functional
development of the fetus. In Cunningham F, MacDonald P, Gant N [eds.] Williams
Obstetrics. Eighteenth edition, 1989. Appleton & Lange, East Norwalk.
8. Shutt DA, Lopata A: The secretion of
hormones during the culture of human preimplantation embryos with corona cells.
Fertil Steril 35:413-6, 1981.
9. Laufer N, DeCherney AH, Haseltine FP,
et al.: Steroid secretion by the human egg-corona-cumulus complex in culture. J
Clin Endocrinol Metab 58:1153-7, 1984.
10. Punnonen R, Lukola A: Binding of
estrogen and progestin in the human fallopian tube. Fertil Steril 36:610-4,
1981.
11. Hsueh AJ, Peck EJ, Jr., clark JH:
Progesterone antagonism of the oestrogen receptor and oestrogen-induced uterine
growth. Nature 254:337-9, 1975.
12. Bonduelle ML, Dodd R, Liebaers I, et
al.: Chorionic gonadotrophin-beta mRNA, a trophoblast marker, is expressed in
human 8-cell embryos derived from tripronucleate zygotes. Hum Reprod 3:909-14,
1988.
13. Lopata A, Hay DL: The surplus human
embryo: its potential for growth, blastulation, hatching, and human chorionic
gonadotropin production in culture. Fertil Steril 51:984-91, 1989.
14. Hay DL, Lopata A: Chorionic gonadotropin
secretion by human embryos in vitro. J Clin Endocrinol Metab 67:1322-4, 1988.
15. Enders AC: Embryo implantation, with
emphasis on the rhesus monkey and the human. Reproduccion 5:163-7, 1981.
16. Tulchinsky D, Hobel CJ: Plasma human
chorionic gonadotropin, estrone, estradiol, estriol, progesterone, and 17
alpha-hydroxyprogesterone in human pregnancy. 3. Early normal pregnancy. Am J
Obstet Gynecol 117:884-93, 1973.
17. Chard T: Proteins of the human placenta:
some general concepts. p. In Grudzinskas J, Teisner B, Sepala M [eds.]
Pregnancy Proteins: Biology, Chemistry and Clinical Application. Academic
Press, San Diego, 1982.
18. Saijonmaa O, Laatikainen T, Wahlstrom T:
Corticotrophin-releasing factor in human placenta: localization, concentration
and release in vitro. Placenta 9:373-85, 1988.
19. Khodr GS, Siler-Khodr TM: Placental
luteinizing hormone-releasing factor and its synthesis. Science 207:315-7,
1980.
20. Shambaugh G, 3rd, Kubek M, Wilber JF:
Thyrotropin-releasing hormone activity in the human placenta. J Clin Endocrinol
Metab 48:483-6, 1979.
21. Al-Timimi A, Fox H: Immunohistochemical
localization of follicle-stimulating hormone, luteinizing hormone, growth
hormone, adrenocorticotrophic hormone and prolactin in the human placenta.
Placenta 7:163-72, 1986.
22. Hay DL: Placental histology and the production
of human choriogonadotrophin and its subunits in pregnancy. Br J Obstet
Gynaecol 95:1268-75, 1988.
23. Harada A, Hershman JM: Extraction of
human chorionic thyrotropin (hCT) from term placentas: failure to recover
thyrotropic activity. J Clin Endocrinol Metab 47:681-5, 1978.
24. Steiner D: Peptide hormone precursors:
biosynthesis, processing, and significance. p. 49. In Parson J [eds.] Peptide
Hormones. University Park Press, Baltimore, 1976.
25. Hoshina M, Hussa R, Pattillo R, et al.:
The role of trophoblast differentiation in the control of the hCG and hPL
genes. Adv Exp Med Biol 176:299-312, 1984.
26. Hoshina M, Boime I, Mochizuki M:
[Cytological localization of hPL, hCG, and mRNA in chorionic tissue using in
situ hybridization]. Nippon Sanka Fujinka Gakkai Zasshi 36:397-404, 1984.
27. Kurman RJ, Young RH, Norris HJ, et al.:
Immunocytochemical localization of placental lactogen and chorionic
gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on
intermediate trophoblast and the placental site trophoblastic tumor. Int J
Gynecol Pathol 3:101-21, 1984.
28. Kasai K, Aochi H, Shik SS, et al.:
[Production and localization of human prolactin in the tissues associated with
pregnancy (Report I) (author's transl)]. Nippon Naibunpi Gakkai Zasshi
56:1574-80, 1980.
29. Watkins WB, Yen SS: Somatostatin in
cytotrophoblast of the immature human placenta: localization by
immunoperoxidase cytochemistry. J Clin Endocrinol Metab 50:969-71, 1980.
30. Chard T, Grudzinskas JG: Pregnancy
protein secretion. Semin Reprod Endocrinol 10:61, 1992.
31. Jones EE: Abnormal ovulation and
implantation. p. 187. In Reece EA, Hobbins JC [eds.] Medicine of the mother and
fetus. JB Lippincott Company, Philadelphia, 1992.
32. Murphy BEP: Cortisol economy in the
human fetus. p. 509. In James VHT, Serio M, Gusti G [eds.] The Endocrine
Function of the Human Adrenal Cortex. Academic Press, San Diego, 1978.
33. Murphy BE: Cortisol and cortisone in
human fetal development. J Steroid Biochem 11:509-13, 1979.
34. Handwerger S, Brar A: Placental
lactogen, placental growth hormone, and decidual prolactin. Semin Reprod
Endocrinol 10:106, 1992.
35. Maslar IA, Ansbacher R: Effects of
progesterone on decidual prolactin production by organ cultures of human
endometrium. Endocrinology 118:2102-8, 1986.
36. Raabe MA, McCoshen JA: Epithelial
regulation of prolactin effect on amnionic permeability. Am J Obstet Gynecol
154:130-4, 1986.
37. Clements JA, Reyes FI, Winter JS, et
al.: Studies on human sexual development. IV. Fetal pituitary and serum, and
amniotic fluid concentrations of prolactin. J Clin Endocrinol Metab 44:408-13,
1977.
38. Luciano AA, Varner MW: Decidual,
amniotic fluid, maternal and fetal prolactin in normal and abnormal
pregnancies. Obstet Gynecol 63:384-8, 1984.
39. Pullano JG, Cohen-Addad N, Apuzzio JJ,
et al.: Water and salt conservation in the human fetus and newborn. I. Evidence
for a role of fetal prolactin. J Clin Endocrinol Metab 69:1180-6, 1989.
40. Golander A, Kopel R, Lazebnik N, et al.:
Decreased prolactin secretion by decidual tissue of pre-eclampsia in vitro.
Acta Endocrinol (Copenh) 108:111-3, 1985.
41. Healy DL, Herington AC, O'Herlihy C:
Chronic polyhydramnios is a syndrome with a lactogen receptor defect in the
chorion laeve. Br J Obstet Gynaecol 92:461-7, 1985.
42. McCoshen JA, Barc J: Prolactin
bioactivity following decidual synthesis and transport by amniochorion. Am J
Obstet Gynecol 153:217-23, 1985.
43. Rutanen E: Insulin-like growth factor
binding protein-1. Semin Reprod Endocrinol 10:154, 1992.
44. Seppala M, Riittinen L, Kamarainen M:
Placental protein 14/progesterone-associated endoemtrial protein revisited.
Semin Reprod Endocrinol 10:164, 1992.
45. Julkunen M, Rutanen EM, Koskimies A, et
al.: Distribution of placental protein 14 in tissues and body fluids during
pregnancy. Br J Obstet Gynaecol 92:1145-51, 1985.
46. Stabile I, Olajide F, Chard T, et al.:
Circulating levels of placental protein 14 in ectopic pregnancy. Br J Obstet
Gynaecol 101:762-4, 1994.
47. Carr BR, MacDonald PC, Simpson ER: The
role of lipoproteins in the regulation of progesterone secretion by the human
corpus luteum. Fertil Steril 38:303-11, 1982.
48. Csapo AI, Pulkkinen MO, Wiest WG:
Effects of luteectomy and progesterone replacement therapy in early pregnant
patients. Am J Obstet Gynecol 115:759-65, 1973.
49. Sauer MV, Paulson RJ, Lobo RA: A
preliminary report on oocyte donation extending reproductive potential to women
over 40. N Engl J Med 323:1157-60, 1990.
50. Yen SS: Endocrine-metabolic adaptations
in pregnancy. p. 940. In Yen SSC, Jaffe RB, Barbieri RL [eds.] Reproductive
endocrinology: physiology, pathophysiology and clinical management. WB Saunders
Company, Philadelphia, 1991.
51. Nygren KG, Johansson ED, Wide L:
Evaluation of the prognosis of threatened abortion from the peripheral plasma
levels of progesterone, estradiol, and human chorionic gonadotropin. Am J
Obstet Gynecol 116:916-22, 1973.
52. Stovall TG, Ling FW, Carson SA, et al.:
Serum progesterone and uterine curettage in differential diagnosis of ectopic
pregnancy. Fertil Steril 57:456-7, 1992.
53. Tulchinsky D, Hobel CJ, Yeager E, et
al.: Plasma estrone, estradiol, estriol, progesterone, and
17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy. Am J Obstet
Gynecol 112:1095-100, 1972.
54. Dicztalusy E: Steroid metabolism in the
feto-placental unit. p. In Pecile A, Finzi C [eds.] The Feto-Placental Unit.
Excerpta Medica, Amsterdam, 1969.
55. Pepe GJ, Albrecht ED: Actions of
placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev
16:608-48, 1995.
56. Abraham GE, Odell WD, Swerdloff RS, et
al.: Simultaneous radioimmunoassay of plasma FSH, LH, progesterone,
17-hydroxyprogesterone, and estradiol-17 beta during the menstrual cycle. J
Clin Endocrinol Metab 34:312-8, 1972.
57. Lindberg BS, Johansson ED, Nilsson BA:
Plasma levels of nonconjugated oestrone, oestradiol-17beta and oestriol during
uncomplicated pregnancy. Acta Obstet Gynecol Scand Suppl 32:21-36, 1974.
58. Yen SS: Endocrine-metabolic adaptations
in pregnancy. p. 943. In Yen SSC, Jaffe RB, Barbieri RL [eds.] Reproductive
endocrinology: physiology, pathophysiology and clinical management. WB Saunders
Company, Philadelphia, 1991.
59. Siiteri PK, Febres F, Clemens LE, et
al.: Progesterone and maintenance of pregnancy: is progesterone nature's
immunosuppressant? Ann N Y Acad Sci 286:384-97, 1977.
60. Moriyama I, Sugawa T: Progesterone
facilitates implantation of xenogenic cultured cells in hamster uterus. Nat New
Biol 236:150-2, 1972.
61. Partsch CJ, Sippell WG, MacKenzie IZ, et
al.: The steroid hormonal milieu of the undisturbed human fetus and mother at
16-20 weeks gestation. J Clin Endocrinol Metab 73:969-74, 1991.
62. Tulchinsky D, Simmer HH: Sources of
plasma 17alpha-hydroxyprogesterone in human pregnancy. J Clin Endocrinol Metab
35:799-808, 1972.
63. Siiteri PK, MacDonald PC: Placental
estrogen biosynthesis during human pregnancy. J Clin Endocrinol Metab
26:751-61, 1966.
64. Bradshaw KD, Carr BR: Placental
sulfatase deficiency: maternal and fetal expression of steroid sulfatase
deficiency and X-linked ichthyosis. Obstet Gynecol Surv 41:401-13, 1986.
65. Simpson ER, Mahendroo MS, Means GD, et
al.: Aromatase cytochrome P450, the enzyme responsible for estrogen
biosynthesis. Endocr Rev 15:342-55, 1994.
66. Yen SS: Endocrine-metabolic adaptations
in pregnancy. p. 947. In Yen SSC, Jaffe RB, Barbieri RL [eds.] Reproductive
endocrinology: physiology, pathophysiology and clinical management. WB Saunders
Company, Philadelphia, 1991.
67. Resnik R, Killam AP, Battaglia FC, et
al.: The stimulation of uterine blood flow by various estrogens. Endocrinology
94:1192-6, 1974.
68. Henson MC, Pepe GJ, Albrecht ED:
Regulation of placental low-density lipoprotein uptake in baboons by estrogen:
dose-dependent effects of the anti-estrogen ethamoxytriphetol (MER-25). Biol
Reprod 45:43-8, 1991.
69. Tulchinsky D, Hobel CJ, Korenman SG: A
radioligand assay for plasma unconjugated estriol in normal and abnormal
pregnancies. Am J Obstet Gynecol 111:311-8, 1971.
70. Landon MB, Gabbe SG: Fetal surveillance
in the pregnancy complicated by diabetes mellitus. Clin Obstet Gynecol
34:535-43, 1991.
71. Klopper A, Masson G, Campbell D, et al.:
Estriol in plasma. A compartmental study. Am J Obstet Gynecol 117:21-6, 1973.
72. Solomon S: The placenta as an endocrine
organ: steroids. p. 2086. In Knobil E, Neill JD [eds.] The physiology of
reproduction. Raven Press Ltd., New York, 1988.
73. Barnea ER, Kaplan M: Spontaneous,
gonadotropin-releasing hormone-induced, and progesterone-inhibited pulsatile
secretion of human chorionic gonadotropin in the first trimester placenta in
vitro. J Clin Endocrinol Metab 69:215-7, 1989.
74. Chrousos GP, Calabrese JR, Avgerinos P,
et al.: Corticotropin releasing factor: basic studies and clinical
applications. Prog Neuropsychopharmacol Biol Psychiatry 9:349-59, 1985.
75. Stalla GK, Hartwimmer J, von Werder K,
et al.: Ovine (o) and human (h) corticotrophin releasing factor (CRF) in man:
CRF-stimulation and CRF-immunoreactivity. Acta Endocrinol (Copenh) 106:289-97,
1984.
76. Shibahara S, Morimoto Y, Furutani Y, et
al.: Isolation and sequence analysis of the human corticotropin-releasing
factor precursor gene. Embo J 2:775-9, 1983.
77. Stalla GK, Bost H, Stalla J, et al.:
Human corticotropin-releasing hormone during pregnancy. Gynecol Endocrinol
3:1-10, 1989.
78. Laatikainen TJ, Raisanen IJ, Salminen
KR: Corticotropin-releasing hormone in amniotic fluid during gestation and
labor and in relation to fetal lung maturation. Am J Obstet Gynecol 159:891-5,
1988.
79. Jones SA, Brooks AN, Challis JR:
Steroids modulate corticotropin-releasing hormone production in human fetal
membranes and placenta. J Clin Endocrinol Metab 68:825-30, 1989.
80. Robinson BG, Emanuel RL, Frim DM, et
al.: Glucocorticoid stimulates expression of corticotropin-releasing hormone
gene in human placenta. Proc Natl Acad Sci U S A 85:5244-8, 1988.
81. Linton EA, Perkins AV, Woods RJ, et al.:
Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels
decrease during the third trimester of normal human pregnancy. J Clin
Endocrinol Metab 76:260-2, 1993.
82. Sug-Tang A, Bocking AD, Brooks AN, et
al.: Effects of restricting uteroplacental blood flow on concentrations of
corticotrophin-releasing hormone, adrenocorticotrophin, cortisol, and
prostaglandin E2 in the sheep fetus during late pregnancy. Can J Physiol
Pharmacol 70:1396-402, 1992.
83. Clifton VL, Read MA, Leitch IM, et al.:
Corticotropin-releasing hormone-induced vasodilatation in the human fetal
placental circulation. J Clin Endocrinol Metab 79:666-9, 1994.
84. Perkins AV, Linton EA, Eben F, et al.:
Corticotrophin-releasing hormone and corticotrophin-releasing hormone binding
protein in normal and pre-eclamptic human pregnancies. Br J Obstet Gynaecol
102:118-22, 1995.
85. Goland RS, Jozak S, Warren WB, et al.:
Elevated levels of umbilical cord plasma corticotropin-releasing hormone in
growth-retarded fetuses. J Clin Endocrinol Metab 77:1174-9, 1993.
86. Ruth V, Hallman M, Laatikainen T:
Corticotropin-releasing hormone and cortisol in cord plasma in relation to
gestational age, labor, and fetal distress. Am J Perinatol 10:115-8, 1993.
87. Goland RS, Conwell IM, Warren WB, et
al.: Placental corticotropin-releasing hormone and pituitary-adrenal function
during pregnancy. Neuroendocrinology 56:742-9, 1992.
88. Youngblood WW, Humm J, Lipton MA, et
al.: Thyrotropin-releasing hormone-like bioactivity in placenta: evidence for
the existence of substances other than Pyroglu-His-Pro-NH2 (TRH) capable of
stimulating pituitary thyrotropin release. Endocrinology 106:541-6, 1980.
89. Taliadouros GS, Canfield RE, Nisula BC:
Thyroid-stimulating activity of chorionic gonadotropin and luteinizing hormone.
J Clin Endocrinol Metab 47:855-60, 1978.
90. Ren SG, Braunstein GD: Human chorionic
gonadotropin. Semin Reprod Endocrinol 10:95, 1992.
91. Mersol-Barg MS, Miller KF, Choi CM, et
al.: Inhibin suppresses human chorionic gonadotropin secretion in term, but not
first trimester, placenta. J Clin Endocrinol Metab 71:1294-8, 1990.
92. Hanson FW, Powell JE, Stevens VC:
Effects of HCG and human pituitary LH on steroid secretion and functional life
of the human corpus luteum. J Clin Endocrinol Metab 32:211-5, 1971.
93. Nisula BC, Ketelslegers JM:
Thyroid-stimulating activity and chorionic gonadotropin. J Clin Invest
54:494-9, 1974.
94. Seron-Ferre M, Lawrence CC, Jaffee RB:
Role of hCG in the regulation of the fetal adrenal gland. J Clin Endocrinol
Metab 46:834, 1978.
95. Huhtaniemi IT, Korenbrot CC, Jaffe RB:
HCG binding and stimulation of testosterone biosynthesis in the human fetal
testis. J Clin Endocrinol Metab 44:963-7, 1977.
96. Hodgen GD, Itskovitz J: Recognition and
maintenance of pregnancy. p. 2009. In Knobil E, Neill JD [eds.] The physiology
of reproduction. Raven Press Ltd., New York, 1988.
97. Frankenne F, Closset J, Gomez F, et al.:
The physiology of growth hormones (GHs) in pregnant women and partial
characterization of the placental GH variant. J Clin Endocrinol Metab
66:1171-80, 1988.
98. Eriksson L, Frankenne F, Eden S, et al.:
Growth hormone secretion during termination of pregnancy. Further evidence of a
placental variant. Acta Obstet Gynecol Scand 67:549-52, 1988.
99. Eriksson L: Growth hormone in human
pregnancy. Maternal 24-hour serum profiles and experimental effects of
continuous GH secretion. Acta Obstet Gynecol Scand Suppl 147:1-38, 1989.
100. Eriksson L, Frankenne F, Eden S, et al.:
Growth hormone 24-h serum profiles during pregnancy--lack of pulsatility for
the secretion of the placental variant. Br J Obstet Gynaecol 96:949-53, 1989.
101. Mirlesse V, Frankenne F, Alsat E, et al.:
Placental growth hormone levels in normal pregnancy and in pregnancies with
intrauterine growth retardation. Pediatr Res 34:439-42, 1993.
102. Takata K, Kasahara T, Kasahara M, et al.:
Localization of erythrocyte/HepG2-type glucose transporter (GLUT1) in human
placental villi. Cell Tissue Res 267:407-12, 1992.
103. Hauguel-de Mouzon S, Leturque A, Alsat E,
et al.: Developmental expression of Glut1 glucose transporter and c-fos genes
in human placental cells. Placenta 15:35-46, 1994.
104. MacLeod JN, Lee AK, Liebhaber SA, et al.:
Developmental control and alternative splicing of the placentally expressed
transcripts from the human growth hormone gene cluster. J Biol Chem
267:14219-26, 1992.
105. de Zegher F, Vanderschueren-Lodeweyckx M,
Spitz B, et al.: Perinatal growth hormone (GH) physiology: effect of
GH-releasing factor on maternal and fetal secretion of pituitary and placental
GH. J Clin Endocrinol Metab 71:520-2, 1990.
106. Evain-Brion D, Alsat E, Mirlesse V, et
al.: Regulation of growth hormone secretion in human trophoblastic cells in
culture. Horm Res 33:256-9, 1990.
107. Han VK, Bassett N, Walton J, et al.: The
expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP)
genes in the human placenta and membranes: evidence for IGF-IGFBP interactions
at the feto-maternal interface. J Clin Endocrinol Metab 81:2680-93, 1996.
108. Raben MS, Matsuzaki F, Minton PR:
Growth-Promoting and Metabolic Effects of Growth Hormone. Metabolism
13:SUPPL:1102-7, 1964.
109. Salomon F, Cuneo RC, Hesp R, et al.: The
effects of treatment with recombinant human growth hormone on body composition
and metabolism in adults with growth hormone deficiency. N Engl J Med
321:1797-803, 1989.
110. Yen SS: Endocrine-metabolic adaptations in
pregnancy. p. 958. In Yen SSC, Jaffe RB, Barbieri RL [eds.] Reproductive
endocrinology: physiology, pathophysiology and clinical management. WB Saunders
Company, Philadelphia, 1991.
111. Niall HD, Hogan ML, Sauer R, et al.:
Sequences of pituitary and placental lactogenic and growth hormones: evolution
from a primordial peptide by gene reduplication. Proc Natl Acad Sci U S A
68:866-70, 1971.
112. Braunstein GD, Rasor JL, Engvall E, et
al.: Interrelationships of human chorionic gonadotropin, human placental
lactogen, and pregnancy-specific beta 1-glycoprotein throughout normal human
gestation. Am J Obstet Gynecol 138:1205-13, 1980.
113. Kim YJ, Felig P: Plasma chorionic
somatomammotropin levels during starvation in midpregnancy. J Clin Endocrinol
Metab 32:864-7, 1971.
114. Furlanetto RW, Underwood LE, Van Wyk JJ,
et al.: Serum immunoreactive somatomedin-C is elevated late in pregnancy. J
Clin Endocrinol Metab 47:695-8, 1978.
115. Kirwan JP, Hauguel-De Mouzon S, Lepercq J,
et al.: TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes
51:2207-13, 2002.
116. Navot D, Scott RT, Droesch K, et al.: The
window of embryo transfer and the efficiency of human conception in vitro.
Fertil Steril 55:114-8, 1991.
117. Lenton EA, Neal LM, Sulaiman R: Plasma
concentrations of human chorionic gonadotropin from the time of implantation
until the second week of pregnancy. Fertil Steril 37:773-8, 1982.
118. Kosasa T, Levesque L, Goldstein DP, et
al.: Early detection of implantation using a radioimmunoassay specific for
human chorionic gonadotropin. J Clin Endocrinol Metab 36:622-4, 1973.
119. Cavanagh AC, Morton H: The purification of
early-pregnancy factor to homogeneity from human platelets and identification
as chaperonin 10. Eur J Biochem 222:551-60, 1994.
120. Di Trapani G, Orosco C, Perkins A, et al.:
Isolation from human placental extracts of a preparation possessing 'early
pregnancy factor' activity and identification of the polypeptide components.
Hum Reprod 6:450-7, 1991.
121. Zuo X, Su B, Wei D: Isolation and
characterization of early pregnancy factor. Chin Med Sci J 9:34-7, 1994.
122. Mehta AR, Eessalu TE, Aggarwal BB:
Purification and characterization of early pregnancy factor from human
pregnancy sera. J Biol Chem 264:2266-71, 1989.
123. Clarke FM: Identification of molecules and
mechanisms involved in the 'early pregnancy factor' system. Reprod Fertil Dev
4:423-33, 1992.
124. Chard T, Grudzinskas JG: Early pregnancy
factor. Biol Res Pregnancy Perinatol 8:53-6, 1987.
125. Mesrogli M, Schneider J, Maas DH: Early
pregnancy factor as a marker for the earliest stages of pregnancy in infertile
women. Hum Reprod 3:113-5, 1988.
126. Shahani SK, Moniz CL, Bordekar AD, et al.:
Early pregnancy factor as a marker for assessing embryonic viability in
threatened and missed abortions. Gynecol Obstet Invest 37:73-6, 1994.
127. Straube W, Romer T, Zeenni L, et al.: [The
early pregnancy factor (EPF) as an early marker of disorders in pregnancy].
Zentralbl Gynakol 117:32-4, 1995.
128. Hubel V, Straube W, Loh M, et al.: Human
early pregnancy factor and early pregnancy associated protein before and after
therapeutic abortion in comparison with beta-hCG, estradiol, progesterone and
17-hydroxyprogesterone. Exp Clin Endocrinol 94:171-6, 1989.
129. Rees LH, Burke CW, Chard T, et al.:
Possible placental origin of ACTH in normal human pregnancy. Nature 254:620-2,
1975.
130. Genazzani AR, Fraioli F, Hurlimann J, et
al.: Immunoreactive ACTH and cortisol plasma levels during pregnancy. Detection
and partial purification of corticotrophin-like placental hormone: the human
chorionic corticotrophin (HCC). Clin Endocrinol (Oxf) 4:1-14, 1975.
131. Petraglia F, Sawchenko PE, Rivier J, et
al.: Evidence for local stimulation of ACTH secretion by
corticotropin-releasing factor in human placenta. Nature 328:717-9, 1987.
132. Nolten WE, Rueckert PA: Elevated free
cortisol index in pregnancy: possible regulatory mechanisms. Am J Obstet
Gynecol 139:492-8, 1981.
133. Prager D, Weber MM, Herman-Bonert V:
Placental growth factors and releasing/inhibiting peptides. Semin Reprod
Endocrinol 10:83, 1992.
134. Abe Y, Hasegawa Y, Miyamoto K, et al.:
High concentrations of plasma immunoreactive inhibin during normal pregnancy in
women. J Clin Endocrinol Metab 71:133-7, 1990.
135. Tovanabutra S, Illingworth PJ, Ledger WL,
et al.: The relationship between peripheral immunoactive inhibin, human
chorionic gonadotrophin, oestradiol and progesterone during human pregnancy.
Clin Endocrinol (Oxf) 38:101-7, 1993.
136. Petraglia F, Sawchenko P, Lim AT, et al.:
Localization, secretion, and action of inhibin in human placenta. Science
237:187-9, 1987.
137. Muttukrishna S, George L, Fowler PA, et
al.: Measurement of serum concentrations of inhibin-A (alpha-beta A dimer)
during human pregnancy. Clin Endocrinol (Oxf) 42:391-7, 1995.
138. Khong TY, Healy DL, Findlay JK, et al.:
Inhibin and the human placenta: a critique. Reprod Fertil Dev 3:391-5, 1991.
139. Petraglia F: Inhibin, activin and
follistatin in the human placenta--a new family of regulatory proteins.
Placenta 18:3-8, 1997.
140. Mills NC, D'Ercole AJ, Underwood LE, et
al.: Synthesis of somatomedin C/insulin-like growth factor I by human placenta.
Mol Biol Rep 11:231-6, 1986.
141. Jonas HA, Harrison LC: The human placenta
contains two distinct binding and immunoreactive species of insulin-like growth
factor-I receptors. J Biol Chem 260:2288-94, 1985.
142. Grizzard JD, D'Ercole AJ, Wilkins JR, et
al.: Affinity-labeled somatomedin-C receptors and binding proteins from the
human fetus. J Clin Endocrinol Metab 58:535-43, 1984.
143. Lenton EA, Grudzinskas JG, Gordon YB, et
al.: Pregnancy specific beta 1 glycoprotein and chorionic gonadotrophin in
early human pregnancy. Acta Obstet Gynecol Scand 60:489-92, 1981.
144. Chou JY, Plouzek CA: Pregnancy-specific
3t-glycoprotein. Semin Reprod Endocrinol 10:116, 1992.
145. Tatarinov YS: Trophoblast-specific
beta1-glycoprotein as a marker for pregnancy and malignancies. Gynecol Obstet
Invest 9:65-97, 1978.
146. Sinosich MJ, Teisner B, Folkersen J, et
al.: Radioimmunoassay for pregnancy-associated plasma protein A. Clin Chem
28:50-3, 1982.
147. Bischof P: Pregnancy-associated plasma
protein-A. Semin Reprod Endocrinol 10:127, 1992.
148. Westergaard JG, Teisner B, Sinosich MJ, et
al.: Does ultrasound examination render biochemical tests obsolete in the
prediction of early pregnancy failure? Br J Obstet Gynaecol 92:77-83, 1985.
149. Dumps P, Meisser A, Pons D, et al.:
Accuracy of single measurements of pregnancy-associated plasma protein-A, human
chorionic gonadotropin and progesterone in the diagnosis of early pregnancy
failure. Eur J Obstet Gynecol Reprod Biol 100:174-80, 2002.
150. Obiekwe B, Pendlebury DJ, Gordeon YB, et
al.: The radioimmunoassay of placental protein 5 and circulating levels in
maternal blood in the third trimester of normal pregnancy. Clin Chim Acta
95:509-16, 1979.
151. Salem HT, Seppala M, Chard T: The effect
of thrombin on serum placental protein 5 (PP5): is PP5 the naturally occurring
antithrombin III of the human placenta? Placenta 2:205-9, 1981.
152. Flood JT, Hodgen GD: The physiology of
fertilization, implantation and early human development. p. 88. In Scott JR,
Desaia PJ [eds.] Danforth's Obstetrics and Gynecology. JB Lippincott Company,
Philadelphia, 1990.
153. Winn VD, Haimov-Kochman R, Paquet AC, et
al.: Gene expression profiling of the human maternal-fetal interface reveals
dramatic changes between midgestation and term. Endocrinology 148:1059-79,
2007.
154. Parker CR: The endocrinology of pregnancy.
p. 28. In Carr BR, Blackwell RE [eds.] Textbook of Reproductive Medicine.
Appleton & Lange, Norwalk, 1993.
155. Johannison E: The foetal adrenal cortex in
the human. Acta Endocrinol 58(Suppl. 130):7, 1968.
156. Honour JH, Wickramaratne K, Valman HB:
Adrenal function in preterm infants. Biol Neonate 61:214-21, 1992.
157. Hutchinson KA, DeCherney AH: The endocrinology
of pregnancy. p. 105. In Reece EA, Hobbins JC [eds.] Medicine of the mother and
fetus. JB Lippincott Company, Philadelphia, 1999.
158. The morphological and functional
development of the fetus. In Cunningham FG, MacDonald PC, Gant NF [eds.] Williams
Obstetrics. Eighteenth edition, 1989. Appleton & Lange, East Norwalk.
159. Alpert E, Drysdale JW, Isselbacher KJ, et
al.: Human -fetoprotein. Isolation, characterization, and demonstration of
microheterogeneity. J Biol Chem 247:3792-8, 1972.
160. Gitlin D, Perricelli A, Gitlin GM:
Synthesis of -fetoprotein by liver, yolk sac, and gastrointestinal tract of the
human conceptus. Cancer Res 32:979-82, 1972.
161. Habib ZA: Maternal serum
alpha-feto-protein: its value in antenatal diagnosis of genetic disease and in
obstetrical-gynaecological care. Acta Obstet Gynecol Scand Suppl 61:1-92, 1977.
162. Murgita RA, Tomasi TB, Jr.: Suppression of
the immune response by alpha-fetoprotein on the primary and secondary antibody
response. J Exp Med 141:269-86, 1975.
163. Ferguson-Smith MA, Rawlinson HA, May HM,
et al.: Avoidance of anencephalic and spina bifida births by maternal
serum-alphafetoprotein screening. Lancet 1:1330-3, 1978.
164. Wald N, Cuckle H: AFP and age screening
for Down syndrome. Am J Med Genet 31:197-209, 1988.
165. Burrow GN, Fisher DA, Larsen PR: Maternal
and fetal thyroid function. N Engl J Med 331:1072-8, 1994.
166. Pepe GJ, Waddell BJ, Albrecht ED: The
effects of adrenocorticotropin and prolactin on adrenal dehydroepiandrosterone
secretion in the baboon fetus. Endocrinology 122:646-50, 1988.
167. Pepe GJ, Albrecht ED: Regulation of the
primate fetal adrenal cortex. Endocr Rev 11:151-76, 1990.
168. Albrecht ED, Pepe GJ: Placental steroid
hormone biosynthesis in primate pregnancy. Endocr Rev 11:124-50, 1990.
169. Carr BR, MacDonald PC, Simpson ER: The
regulation of de novo synthesis of cholesterol in the human fetal adrenal gland
by low density lipoprotein and adrenocorticotropin. Endocrinology 107:1000-6,
1980.
170. Carr BR, Porter JC, MacDonald PC, et al.:
Metabolism of low density lipoprotein by human fetal adrenal tissue.
Endocrinology 107:1034-40, 1980.
171. Parker CR, Jr., Carr BR, Winkel CA, et
al.: Hypercholesterolemia due to elevated low density lipoprotein-cholesterol
in newborns with anencephaly and adrenal atrophy. J Clin Endocrinol Metab
57:37-43, 1983.
172. Simpson ER, Carr BR, Parker CR, Jr., et
al.: The role of serum lipoproteins in steroidogenesis by the human fetal
adrenal cortex. J Clin Endocrinol Metab 49:146-8, 1979.
173. Winters AJ, Oliver C, Colston C, et al.:
Plasma ACTH levels in the human fetus and neonate as related to age and
parturition. J Clin Endocrinol Metab 39:269-73, 1974.
174. Simpson ER, Parker CR, Jr., Carr BR: Role
of lipoproteins in the regulation of steroidogenesis by the human fetal
adrenal. p. In Jaffe RB, Dell Acqua S [eds.] The Endocrine Physiology of
Pregnancy and the Peripartal Period Vol. 21. Serono Symposia Publications.
Raven Press, New York, 1985.
175. Nieman LK: The endocrinology of pregnancy.
p. 250. [eds.] Serono symposia in Reproductive Endocrinology.
176. Seron-Ferre M, Lawrence CC, Siiteri PK, et
al.: Steroid production by definitive and fetal zones of the human fetal
adrenal gland. J Clin Endocrinol Metab 47:603-9, 1978.
177. Baird A, Kan KW, Solomon S: Role of
pro-opiomelanocortin-derived peptides in the regulation of steroid production
by human fetal adrenal cells in culture. J Endocrinol 97:357-67, 1983.
178. Bugnon C, Lenys D, Bloch B, et al.:
[Cyto-immunologic study of early cell differentiation phenomena in the human
fetal anterior pituitary gland]. C R Seances Soc Biol Fil 168:460-5, 1974.
179. Katikineni M, Davies TF, Catt KJ:
Regulation of adrenal and testicular prolactin receptors by adrenocorticotropin
and luteinizing hormone. Endocrinology 108:2367-74, 1981.
180. Voutilainen R, Miller WL: Coordinate
tropic hormone regulation of mRNAs for insulin-like growth factor II and the
cholesterol side-chain-cleavage enzyme, P450scc [corrected], in human
steroidogenic tissues. Proc Natl Acad Sci U S A 84:1590-4, 1987.
181. Winters AJ, Colston C, MacDonald PC, et
al.: Fetal plasma prolactin levels. J Clin Endocrinol Metab 41:626-9, 1975.
182. Walsh SW, Norman RL, Novy MJ: In utero
regulation of rhesus monkey fetal adrenals: effects of dexamethasone, adrenocorticotropin,
thyrotropin-releasing hormone, prolactin, human chorionic gonadotropin, and
alpha-melanocyte-stimulating hormone on fetal and maternal plasma steroids.
Endocrinology 104:1805-13, 1979.
183. Liggins GC: Endocrinology of the
foeto-maternal unit. p. In Sherman RP [eds.] Human Reproductive Physiology.
Blackwell Scientific Publications, Oxford, 1972.
184. Baggia S, Albrecht ED, Pepe GJ: Regulation
of 11 beta-hydroxysteroid dehydrogenase activity in the baboon placenta by
estrogen. Endocrinology 126:2742-8, 1990.
185. Jost A: The fetal adrenal cortex. p. 426.
In Creep RO, Astwood WB [eds.] Handbook of Physiology. Endocrinology Amer
Physiol Soc, Washington, DC, 1975.
186. Kondo S: Developmental studies on the
Japanese human adrenals, I: ponderal growth. Bull Exp Biol 9:51, 1959.
187. Spector DVS: Handbook of Biological Data.
WB Saunders, Philadelphia. 1956.
188. Fant M, Munro H, Moses AC: An
autocrine/paracrine role for insulin-like growth factors in the regulation of
human placental growth. J Clin Endocrinol Metab 63:499-505, 1986.
189. Han VK, Lund PK, Lee DC, et al.:
Expression of somatomedin/insulin-like growth factor messenger ribonucleic
acids in the human fetus: identification, characterization, and tissue
distribution. J Clin Endocrinol Metab 66:422-9, 1988.
190. Berkowitz GS, Lapinski RH, Lockwood CJ, et
al.: Corticotropin-releasing factor and its binding protein: maternal serum
levels in term and preterm deliveries. Am J Obstet Gynecol 174:1477-83, 1996.
191. McGrath S, McLean M, Smith D, et al.:
Maternal plasma corticotropin-releasing hormone trajectories vary depending on
the cause of preterm delivery. Am J Obstet Gynecol 186:257-60, 2002.
192. Benedetto C, Petraglia F, Marozio L, et
al.: Corticotropin-releasing hormone increases prostaglandin F2 alpha activity
on human myometrium in vitro. Am J Obstet Gynecol 171:126-31, 1994.
193. Karalis K, Goodwin G, Majzoub JA: Cortisol
blockade of progesterone: a possible molecular mechanism involved in the
initiation of human labor. Nat Med 2:556-60, 1996.
194. Case ML, MacDonald PC: Human parturition:
distinction between the initiation of parturition and the onset of labor. Semin
Reprod Endocrinol 11:272, 1993.
195. Olson DM, Zakar T: Intrauterine tissue
prostaglandin synthesis: regulatory mechanisms. Semin Reprod Endocrinol 11:234,
1993.
196. Parker CR, Jr., Leveno K, Carr BR, et al.:
Umbilical cord plasma levels of dehydroepiandrosterone sulfate during human
gestation. J Clin Endocrinol Metab 54:1216-20, 1982.
197. Mesiano S, Chan EC, Fitter JT, et al.:
Progesterone withdrawal and estrogen activation in human parturition are
coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab 87:2924-30, 2002.
198. Csapo AI:
Anti-progesterones in fertility control. p. 16. In Zatuchn'i GI, Sciarra JJ,
Speidel JJ [eds.] Pregnancy Termination: Procedures, Safety and New
Developments. Harper & Row, Hagerstown, 1979.
199. Johnson JW, Austin KL, Jones GS, et al.:
Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature
labor. N Engl J Med 293:675-80, 1975.
200. Yemini M, Borenstein R, Dreazen E, et al.:
Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate. Am J
Obstet Gynecol 151:574-7, 1985.
201. Meis PJ, Klebanoff M, Thom E, et al.:
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone
caproate. N Engl J Med 348:2379-85, 2003.
202. Honnebier WJ, Swaab DF: The influence of
anencephaly upon intrauterine growth of fetus and placenta and upon gestation
length. J Obstet Gynaecol Br Commonw 80:577-88, 1973.
203. Novy MJ: Hormonal regulation of
parturition in primates. p. In Sciara J [eds.] Hormone Cell Interactions in
Reproductive Tissues. Masson Publishing, New York, 1983.
204. Hirst JJ, Chibbar R, Mitchell BF: Role of
oxytocin in the regulation of uterine activity during pregnancy and in the
initiation of labor. Semin Reprod Endocrinol 11:219, 1993.
205. Ducsay CA, Seron-Ferre M, Germain AM, et
al.: Endocrine and uterine activity rhythms in the perinatal period. Semin
Reprod Endocrinol 11:285, 1993.
206. Honnebier MB, Nathanielsz PW: Primate
parturition and the role of the maternal circadian system. Eur J Obstet Gynecol
Reprod Biol 55:193-203, 1994.
207. Patrick J, Challis J, Campbell K, et al.:
Circadian rhythms in maternal plasma cortisol and estriol concentrations at 30
to 31, 34 to 35, and 38 to 39 weeks' gestational age. Am J Obstet Gynecol
136:325-34, 1980.
208. Haluska GJ, Novy MJ: Hormonal modulation
of uterine activity during primate parturition. Semin Reprod Endocrinol 11:272,
1993.
In addition
to the journal and text references listed above, the following sources were
used in the preparation of this chapter:
Gabbe SG,
Niebyl JR, Simpson JL [eds.]. Obstetrics: normal and problems pregnancies. Fifth
edition, 2007.
Benirschke
K, Kaufmann P, Baergen RN [eds.]. Pathology of the human placenta. Fifth
edition, 2006. Springer,
Strauss JF,
Barbieri RL [eds.]. Yen and Jaffe’s Reproductive endocrinology: physiology,
pathophysiology and clinical management. Fifth edition, 2004. Elsevier
Saunders,
Reece EA,
Hobbins JC [eds.]. Clinical obstetrics: the fetus and mother. Third edition, 2007.
Wiley-Blackwell,